Investor Presentaiton

..And Consistent Product Launches.. RECENT KEY PRODUCT LAUNCHES Imipramine 25 MG BRAND ZYRTEC (Q3FY22) IMODIUM (Q3FY22) PROZAC (Q3FY22) TYLENOL (Q3FY22) METOZOLV CRESTOR COZAAR TAZAC, AXID LYRICA IMURAN TOFRANIL LORATIDINE SGC Cetirizine Hydrochloride - 5 MG, 10 MG Loperamide-2 MG Fluoxetine Acetaminophen Extended-Release Tablets USP- 650 mg (OTC). Metoclopramide 10MG Rosuvastatin - 5,10, 20, 40 MG Losartan Potassium – 25, 50 & 100 MG COMPOSITION THERAPY SEGMENT MARKET Antihistamine USA Gastrointestinal UK Central Nervous System US Pain Management US Gastrointestinal Cardiovascular UK 米 UK Cardiovascular UK Nizatidine 150 & 300 MG Gastrointestinal UK Pregabaline-25, 50, 100, 150, 200 & 300 MG Central Nervous System UK Azathioprine 50 MG Immunosuppressant UK Central Nervous System UK RISPERDAL ADVIL MINI PANADOL RAPID MUCINEX Claritin Risperidone Ibuprofen(Min) SGC - 200mg Paracetamol (Rapid) 650mg Mucinex Fast/Sinus Max Antihistamine Australia Central Nervous System UK Pain Management Pain Management Cough & Cold UK USA Australia USA ©2021 - Marksans Pharma Limited, All Rights Reserved. 18

View entire presentation